Infectious complications in cancer patients treated with chemical immunosuppressive agents.
D000380:Agranulocytosis / Q000150:complications; D000917:Antibody Formation; D001803:Blood Transfusion; D006801:Humans; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007167:Immunotherapy; D007239:Infections / Q000209:etiology*; D007945:Leukemia, Lymphoid / Q000150:complications; D007962:Leukocytes / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy*; D009895:Opsonin Proteins; D011552:Pseudomonas Infections / Q000209:etiology / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000276:immunology; D005719:gamma-Globulins / Q000627:therapeutic use
D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D009895:Opsonin Proteins; D005719:gamma-Globulins